Loading Events

« All Events

  • This event has passed.

The Faurecia Biosensing Safety Challenge

February 28, 2020

Biosensing Safety Challenge

The Faurecia Biosensing Safety Challenge is looking for novelnon-invasive, methods of detecting abnormalities in vehicle occupants’ physiology — all with the goal of reducing emergency medical events and increasing road safety.

 $25,000 USD and opportunity to work with a global tech company.

How to enter

Innovators must complete the following steps to enter this challenge:

  • Create a profile on marschallenges.com
  • Click “Accept Challenge” on the Faurecia Biosensing Safety webpage
  • Read and accept the Challenge contest rules, ensuring your organization meets the eligibility criteria
  • Download the Submission Form from the “Resources” tab (https://marschallenges.com/challenge/biosensing/)
  • Upload the completed Submission Form by clicking “Submit Application” on the Faurecia Biosensing Safety webpage by February 28, 2020 11:59 p.m. Eastern Standard Time

Specifically, this challenge is looking for hardware sensors, software technologies, or hardware/software solutions which can:

I. Detect at least one sign, symptom or biomarker* related to one or more of the following medical events:

i) Stroke (e.g. face drooping, slurred speech, dizziness, impaired vision, severe headache etc.)

ii) Heart attack (e.g. heart rate, pulse, shortness of breath, chest discomfort, cardiac troponin etc.)

iii) Diabetic event, such as a hypoglycemic episode (e.g. sweating, pallor, shakiness, blood glucose, etc.)

See here for more signs, symptoms and biomarkers.

II. Detect signs, symptoms or biomarkers in a non-invasive manner (e.g. no skin break, contact with mucosa, or any internal body cavity)

III. Have the potential to be integrated into the interior of a vehicle (see FAQ for more details)

IV. Have a technology readiness level (TRL) minimum of 3 if it is a purely software solution or TRL minimum of 4 if it is a strictly hardware solution or software-hardware combination solution


  • The solution should not diagnose a stroke, heart attack or diabetic event
  • The solution cannot be a regulated medical device and/or technology


February 28, 2020